Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yves Allory

14PUBLICATIONS
89CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

Sort by Publication Date:
|Oct 31, 2024
Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer.

Yohann Loriot, Maud Kamal, Laurene Syx

|Oct 04, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancer.

Yohann Loriot, Maud Kamal, Laurene Syx

|Jul 29, 2024
Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors.

Zakhia El Beaino, Célia Dupain, Grégoire Marret

|Jul 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.

Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon

|Dec 28, 2023
Impact of Divergent Differentiation and/or Histological Subtype of Urothelial Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial.

Yves Allory, Stephane Culine, Clémentine Krucker

|Mar 29, 2023
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.

Stéphane Culine, Valentin Harter, Clémentine Krucker

Pageof 3

Frequent Collaborators

4 joint publications

Maud Kamal

3 joint publications

Nicolas Servant

3 joint publications

Jean-Yves Scoazec

3 joint publications

Christian Pfister

3 joint publications

Christophe Le Tourneau

3 joint publications

Fabrice Andre

3 joint publications

Valentin Harter

3 joint publications

Yohann Loriot

3 joint publications

Benjamin Besse

2 joint publications

Stéphane Culine

Frequent Collaborators

4 joint publications

Maud Kamal

3 joint publications

Nicolas Servant

3 joint publications

Jean-Yves Scoazec

3 joint publications

Christian Pfister

Top Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on : Nov 05, 2019

6.7K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on : Mar 08, 2022

2.4K
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

10.5K
See more related videos

Top Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on : Nov 05, 2019

6.7K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on : Mar 08, 2022

2.4K
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

10.5K
See more related videos